Literature DB >> 7438561

Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.

R H Kauffmann, W A Herrmann, C J Meijer, M R Daha, L A Vanes.   

Abstract

Sixty-two patients with allergic vasculitis and histological evidence of leukocytoclastic vasculitis were examined to determine whether clinical features, such as course and degree of systemic involvement, could be related to the class of the immunoglobulins in immune complexes (IC) in both the circulation and the vessel wall. Circulating IC were detected with the 125I-C1q-binding assay (C1q-BA), an anti-IgA inhibition binding assay (a-IgA-Inh BA) and the conglutinin-binding assay (Con-BA). Stabilized heat-aggregated IgG, IgA and IgM were used to determine the immunoglobulin class specificity of these assays. With the C1q-BA only aggregated IgG were detected, with the a-IgA-Inh Ba only aggregates containing IgA. With the Con-BA IgG, IgA or IgM in reactive aggregates were identified with class-specific antibodies. For patients with acute cutaneous vasculitis all assays were negative. The a-IgA-Inh BA was frequently positive in sera of patients with chronic cutaneous and acute systemic vasculitis; in the latter group conglutinin-binding IC of the IgG, IgA and IgM class were also detected. Levels in the C1q-BA were high for patients with chronic systemic vasculitis. Comparison of the results of the IC assays with the immunofluorescence studies of the cutaneous vessel walls of the same patients showed agreement between the results of the C1q-BA and deposition of IgG and the results of the a-IgA-Inh BA and IgA deposition. The class of immunoglobulin in conglutinin-binding IC did not correspond as well with the immunoglobulins in vessel walls. This study shows that certain clinical features of allergic vasculitis are related to the composition of the IC in the circulation and in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438561      PMCID: PMC1537026     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome.

Authors:  E H Faille-Kuyber; L Kater; C J Kooiker; E J Dorhout Mees
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

3.  Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis.

Authors:  W F Doe; C C Booth; D L Brown
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

4.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

5.  Cryoglobulins in vasculitis.

Authors:  J J Cream
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

6.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

7.  Immunoglobulin A (IgA) associated glomerulonephritis.

Authors:  D C Lowance; J D Mullins; J J McPhaul
Journal:  Kidney Int       Date:  1973-03       Impact factor: 10.612

8.  Lactoperoxidase coupled to polyacrylamide for radio-iodination of proteins to high specific activity.

Authors:  J I Thorell; I Larsson
Journal:  Immunochemistry       Date:  1974-04

9.  Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin.

Authors:  W M Sams; H N Claman; P F Kohler; R M McIntosh; P Small; M F Mass
Journal:  J Invest Dermatol       Date:  1975-06       Impact factor: 8.551

10.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  7 in total

1.  Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy.

Authors:  P Lesavre; M Digeon; J F Bach
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

2.  Mononuclear phagocyte system Fc-receptor function in patients with seropositive rheumatoid arthritis.

Authors:  S Lobatto; F C Breedveld; J A Camps; E K Pauwels; M L Westedt; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

3.  Presence of immune complex-like material in sera of patients with paraproteinaemia.

Authors:  F Klein; G J Lafeber; Y E Jongepier-Geerdes; A Cats; R H Kauffmann; J J Michiels
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

4.  IgA containing circulating immune complexes and IgA anti-single stranded DNA antibodies in patients with obstructive jaundice.

Authors:  G Ohshio; F Furukawa; K Sekita; T Manabe; T Tobe; Y Hamashima
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Allergic vasculitis. A histological and immunofluorescent study of lesional and non-lesional skin in relation to circulating immune complexes.

Authors:  W A Herrmann; R H Kauffmann; L A van Es; M R Daha; C J Meijer
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.

Authors:  R H Kauffmann; H H de Rooy-Dijk; F Klein; G J Lafeber; A Cats; L A van Es
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

7.  Circulating immune complexes in cutaneous and systemic vasculitis: clinicopathological correlations.

Authors:  J Barratt; M Sindrey; R Summerly; G M Aber; P Naish
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.